Mary Carrington
Overview
Explore the profile of Mary Carrington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
329
Citations
18650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang T, Huang C, Chen H, Huang Y, Pan M, Lee M, et al.
Hepatology
. 2025 Mar;
PMID: 40084945
Background Aims: The human leukocyte antigen (HLA) locus is implicated in hepatocellular carcinoma (HCC) among chronic hepatitis B virus (HBV) carriers. We investigated associations of HLA variants, amino acid polymorphisms,...
2.
Ganta K, McManus M, Blanc R, Wang Q, Jung W, Brody R, et al.
bioRxiv
. 2025 Jan;
PMID: 39763959
Epstein-Barr Virus (EBV) infects over 95% of the world's population and is the most common cause of infectious mononucleosis (IM). Epidemiologic studies have linked EBV with certain cancers or autoimmune...
3.
Ruan D, Fribourg M, Yuki Y, Park Y, Martin M, Yu H, et al.
JCI Insight
. 2024 Oct;
9(21).
PMID: 39388279
Natural killer (NK) cells respond to diseased and allogeneic cells through NKG2A/HLA-E or killer cell immunoglobulin-like receptor (KIR)/HLA-ABC interactions. Correlations between HLA/KIR disparities and kidney transplant pathology suggest an antibody-independent...
4.
Leddy O, Yuki Y, Carrington M, Bryson B, White F
bioRxiv
. 2024 Sep;
PMID: 39314426
Vaccine-elicited T cell responses can contribute to immune protection against emerging infectious disease risks such as antimicrobials-resistant (AMR) microbial pathogens and viruses with pandemic potential, but rapidly identifying appropriate targets...
5.
Nelson G, van Duijn J, Yuki Y, Pau M, Tomaka F, Lavreys L, et al.
J Virol
. 2024 Jul;
98(8):e0028124.
PMID: 39046263
class I variation has the strongest effect genome-wide on outcome after HIV infection, and as such, an understanding of the impact of polymorphism on response to HIV vaccination may inform...
6.
Tano-Menka R, Singh N, Muzhingi I, Li X, Mandanas M, Kaseke C, et al.
Structure
. 2024 May;
32(8):1121-1136.e5.
PMID: 38733995
Immunogenetic studies have shown that specific HLA-B residues (67, 70, 97, and 156) mediate the impact of HLA class I on HIV infection, but the molecular basis is not well...
7.
Hartmann J, Cardoso M, Talarico M, Kenney D, Leone M, Reese D, et al.
Cell
. 2024 Apr;
187(10):2393-2410.e14.
PMID: 38653235
SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and...
8.
Padoan B, Casar C, Krause J, Schultheiss C, Baumdick M, Niehrs A, et al.
Cell Rep
. 2024 Apr;
43(4):114089.
PMID: 38615318
Although natural killer (NK) cells are recognized for their modulation of immune responses, the mechanisms by which human NK cells mediate immune regulation are unclear. Here, we report that expression...
9.
Lim W, Marques Da Costa M, Godefroy K, Jacquet E, Gragert L, Rondof W, et al.
Front Immunol
. 2024 Feb;
14:1265469.
PMID: 38318504
The human leukocyte antigen (HLA) system is a major factor controlling cancer immunosurveillance and response to immunotherapy, yet its status in pediatric cancers remains fragmentary. We determined high-confidence HLA genotypes...
10.
Rodriguez I, Rossi N, Keskus A, Xie Y, Ahmad T, Bryant A, et al.
Am J Hum Genet
. 2024 Feb;
111(3):544-561.
PMID: 38307027
Cervical cancer is caused by human papillomavirus (HPV) infection, has few approved targeted therapeutics, and is the most common cause of cancer death in low-resource countries. We characterized 19 cervical...